journal article·2012-09Open access

Nanophase bone substitute in vivo response to subcutaneous implantation

Jonathan Z. Baskin, Amit Vasanji, James McMasters, Yohannes Soenjaya, Anca M. Barbu, Steven J. Eppell

Abstract

Abstract A collagen‐apatite composite designed as a load‐bearing bone substitute implant is used to characterize the relationship between implant morphology and in vivo behavior. This nanophase bone substitute (NBS) is studied morphologically using a nondestructive imaging technique and biologically using the rodent subcutaneous model. Porosity and pore interconnectivity are correlated with histological outcomes showing cellular invasion occurs with average pore sizes below 100 μm. Crosslinking with D‐ribose is shown to affect cellular infiltration in a dose‐response manner. These data suggest that collagen‐apatite bone substitutes can support cellular infiltration with pore size significantly smaller than 100 μm, an encouraging result regarding development of the NBS into a platform of biomaterials with enhanced mechanical properties. The data also indicate that increasing crosslinking density decreases cellular infiltration of NBS. Thus, modulating mechanical properties of the material by altering crosslink density is likely to produce decreased biological response within the material. © 2012 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 100A: 2462–2473, 2012.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Collagen: Extraction and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (46)

Show source-provided references
1. FrostS. U.S. Bone Graft and Bone Graft Substitute Markets;2009; 9:434–438.
2. 10.1007/s00402-006-0277-410.1007/s00402-006-0277-4 ↗
3. 10.1016/S0749-8063(98)70099-410.1016/S0749-8063(98)70099-4 ↗
4. 10.1016/j.biomaterials.2007.12.03410.1016/j.biomaterials.2007.12.034 ↗
5. 10.1016/j.biomaterials.2003.12.02310.1016/j.biomaterials.2003.12.023 ↗
6. 10.1016/0142-9612(96)85762-010.1016/0142-9612(96)85762-0 ↗
7. 10.2106/00004623-200703000-0002610.2106/00004623-200703000-00026 ↗
8. 10.1055/s-2008-106430210.1055/s-2008-1064302 ↗
9. 10.1097/BPO.0b013e318168d1d410.1097/BPO.0b013e318168d1d4 ↗
10. Hench LL · 2000 · 404
11. 10.1016/j.spinee.2008.11.00410.1016/j.spinee.2008.11.004 ↗
12. 10.1021/bm060879w10.1021/bm060879w ↗
13. 10.1016/j.biomaterials.2005.02.00210.1016/j.biomaterials.2005.02.002 ↗
14. 10.1007/s10439-004-7825-210.1007/s10439-004-7825-2 ↗
15. 10.1038/nbt0794-68910.1038/nbt0794-689 ↗
16. 10.1002/jbm.82004030910.1002/jbm.820040309 ↗
17. 10.1016/S0142-9612(01)00336-210.1016/S0142-9612(01)00336-2 ↗
18. 10.1016/S0142-9612(01)00126-010.1016/S0142-9612(01)00126-0 ↗
19. Development of a novel biomaterial, hydroxyapatite/collagen (HAp/Col) composite for medical use
20. 10.3727/00000000478398377410.3727/000000004783983774 ↗
21. 10.1002/jbm.1030510.1002/jbm.10305 ↗
22. 10.1016/S0142-9612(02)00126-610.1016/S0142-9612(02)00126-6 ↗
23. 10.1016/S0142-9612(00)00305-710.1016/S0142-9612(00)00305-7 ↗
24. 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-910.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9 ↗
25. KenichiS ItohS TanakaJ JunzoI KikuchiM; Japan Science and Technology Agency (Kawaguchi JP) National Institute for Materials (Tsukuba JP) assignee. Artificial Pyramid. USA Patent 6 887 272.2005.
26. TongW. Synthesis of nanometer‐sized apatites using highly ordered collagen structure [Ph.D.]. Cleveland: Case Western Reserve University;2001.
27. Eppell SJ · 2007
28. 10.1002/jbm.a.1042610.1002/jbm.a.10426 ↗
29. 10.1016/S0021-9258(19)77886-710.1016/S0021-9258(19)77886-7 ↗
30. 10.1002/jbm.b.3019610.1002/jbm.b.30196 ↗
31. 10.1016/j.athoracsur.2004.06.03310.1016/j.athoracsur.2004.06.033 ↗
32. Aminodiphosphonate or AI preincubation inhibits calcification of aortic homografts in the rat subdermal model
33. 10.1016/j.actbio.2007.07.00510.1016/j.actbio.2007.07.005 ↗
34. 10.1002/jbm.b.3033110.1002/jbm.b.30331 ↗
35. 10.1089/tea.2007.013410.1089/tea.2007.0134 ↗
36. 10.1056/NEJM19780928299130410.1056/NEJM197809282991304 ↗
37. 10.1002/jor.110008022110.1002/jor.1100080221 ↗
38. Lieber RL · 1994 · 631
39. 10.1002/jbm.82011060710.1002/jbm.820110607 ↗
40. 10.1002/jbm.a.3187510.1002/jbm.a.31875 ↗
41. 10.3109/0300820920901422410.3109/03008209209014224 ↗
42. 10.1016/j.orthres.2004.09.00410.1016/j.orthres.2004.09.004 ↗
43. Immunocytochemical and lectin‐gold characterization of the interface between alveolar bone and implanted hydroxyapatite in the rat
44. 10.1007/s10856-007-3284-210.1007/s10856-007-3284-2 ↗
45. 10.1016/S0142-9612(03)00089-910.1016/S0142-9612(03)00089-9 ↗
46. 10.1016/j.biomaterials.2006.09.01510.1016/j.biomaterials.2006.09.015 ↗